CIK 0001850119
- Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842040295
- Phone
- +1 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,212
- in 5 filings
Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Cowan Chad Chief Scientific Officer | Shares withheld for taxes | −358 | $2.24 | $802 | 1,175,322 |
| 2026-04-01 | Cowan Chad Chief Scientific Officer | Shares withheld for taxes | −1,365 | $2.19 | $3K | 1,175,680 |
| 2026-03-11 | Cowan Chad Chief Scientific Officer | Shares withheld for taxes | −1,431 | $2.73 | $4K | 1,177,045 |
| 2026-02-02 | Cowan Chad Chief Scientific Officer | Grant or award | +135,000 | 1,178,476 | ||
| 2026-02-02 | Cowan Chad Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +265,000 | 265,000 | ||
| 2026-01-02 | Cowan Chad Chief Scientific Officer | Shares withheld for taxes | −1,611 | $1.00 | $2K | 1,043,476 |
| 2025-12-22 | Cowan Chad Chief Scientific Officer | Purchase | +58,060 | $0.85 | $49K | 1,045,087 |
| 2025-11-20 | Cowan Chad Chief Scientific Officer | Sale | −5,462 | $0.50 | $3K | 987,027 |
| 2025-09-18 | Cowan Chad Chief Scientific Officer | Grant or award | +762,543 | 992,489 | ||
| 2025-03-11 | Cowan Chad Chief Scientific Officer | Grant or award | +19,500 | 230,306 | ||
| 2025-03-11 | Cowan Chad Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +19,500 | 19,500 | ||
| 2024-10-01 | Cowan Chad Chief Scientific Officer | Grant or award | +74,376 | 210,806 | ||
| 2024-10-01 | Cowan Chad Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +446,250 | 446,250 |
Page 1 of 1 · 13 trades